Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma

Bone Marrow Transplantation

Volumn 51, Issue 2, 2016, Pages 205-211

  Fuji, S ^a   Fujiwara, H ^b   Nakano, N ^c   Wake, A ^d   Inoue, Y ^a   Fukuda, T ^a   Hidaka, M ^e   Moriuchi, Y ^f   Miyamoto, T ^g   Uike, N ^h   Taguchi, J ⁱ   Eto, T ^j   Tomoyose, T ^k   Kondo, T ^l   Yamanoha, A ^m   Ichinohe, T ⁿ   Atsuta, Y ^o,p   Utsunomiya, A ^c  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b EHIME UNIVERSITY HOSPITAL   (Japan)

^c IMAMURA BUN IN HOSPITAL   (Japan)

^d TORANOMON HOSPITAL   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

^f Sasebo Shiritsu Sogo Hospital   (Japan)

^g KYUSHU UNIVERSITY HOSPITAL   (Japan)

^h NATIONAL KYUSHU CANCER CENTER   (Japan)

ⁱ NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^j HAMANOMACHI HOSPITAL   (Japan)

^k UNIVERSITY OF THE RYUKYUS   (Japan)

^l KYOTO UNIVERSITY HOSPITAL   (Japan)

^m Heart Life Hospital   (Japan)

ⁿ HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^o JAPANESE DATA CENTER FOR HEMATOPOIETIC CELL TRANSPLANTATION   (Japan)

^p NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CONTROLLED STUDY; EARLY INTERVENTION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; T CELL LEUKEMIA; TREATMENT OUTCOME; ALLOGRAFT; CLINICAL TRIAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MIDDLE AGED; MULTICENTER STUDY; REGISTER; TIME FACTOR;

ADOLESCENT; ADULT; AGED; ALLOGRAFTS; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MIDDLE AGED; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84956924452     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2015.265     Document Type: Article

References (21)

1. Ishitsuka K, Tamura K. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. Lancet Oncol 2014; 15: e517-e526
2. Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W Jr et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 2009; 27: 453-459
3. Katsuya H, Yamanaka T, Ishitsuka K, Utsunomiya A, Sasaki H, Hanada S et al. Prognostic index for acute-and lymphoma-type adult T-cell leukemia/lymphoma. J Clin Oncol 2012; 30: 1635-1640
4. Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukushima T, Takatsuka Y et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 2007; 25: 5458-5464
5. Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, Tara M et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemialymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 2001; 113: 375-382
6. Fukushima T, Nomura S, Shimoyama M, Shibata T, Imaizumi Y, Moriuchi Y et al. Japan Clinical Oncology Group (JCOG) Prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A). Br J Haematol 2014; 166: 739-748
7. Kanda J, Hishizawa M, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y et al. Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study. Blood 2012; 119: 2141-2148
8. Ishida T, Hishizawa M, Kato K, Tanosaki R, Fukuda T, Taniguchi S et al. Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study. Blood 2012; 120: 1734-1741
9. Hishizawa M, Kanda J, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y et al. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood 2010; 116: 1369-1376
10. Atsuta Y, Suzuki R, Yoshimi A, Gondo H, Tanaka J, Hiraoka A et al. Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System. Int J Hematol 2007; 86: 269-274
11. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-828
12. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509
13. Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 2013; 48: 452-458
14. Stolzel F, Platzbecker U, Mohr B, Rollig C, Middeke JM, Thiede C et al. Early intervention with allogeneic hematopoietic cell transplantation during chemotherapy-induced aplasia in patients with high-risk acute myeloid leukemia. Leukemia 2013; 27: 2068-2072
15. Mak V, Hamm J, Chhanabhai M, Shenkier T, Klasa R, Sehn LH et al. Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors. J Clin Oncol 2013; 31: 1970-1976
16. Fukushima T, Itonaga H, Moriuchi Y, Yoshida S, Taguchi J, Imaizumi Y et al. Feasibility of cord blood transplantation in chemosensitive adult T-cell leukemia/ lymphoma: a retrospective analysis of the Nagasaki Transplantation Network. Int J Hematol 2013; 97: 485-490
17. Nakamura T, Oku E, Nomura K, Morishige S, Takata Y, Seki R et al. Unrelated cord blood transplantation for patients with adult T-cell leukemia/lymphoma: experience at a single institute. Int J Hematol 2012; 96: 657-663
18. Kato K, Choi I, Wake A, Uike N, Taniguchi S, Moriuchi Y et al. Treatment of patients with adult T cell leukemia/lymphoma with cord blood transplantation: a Japanese nationwide retrospective survey. Biol Blood Marrow Transplant 2014; 20: 1968-1974
19. Luznik L, O'Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 2008; 14: 641-650
20. Bashey A, Zhang X, Sizemore CA, Manion K, Brown S, Holland HK et al. T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation. J Clin Oncol 2013; 31: 1310-1316
21. Fujiwara H, Ozaki A, Yoshimitsu M, Hamada H, Masamoto I, Matsushita K et al. Allogeneic stem cell transplantation for refractory adult T-cell leukemia using a non-T-cell-depleted HLA-incompatible family donor graft, with reference to the grown-up child donor to parent recipient setting: report of a pilot study. Int J Hematol 2008; 87: 319-326